Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Oral vs. Intravenous TXA Study Proposal: TJA

NCT02233101 is registered in ClinicalTrials.gov with Rush University Medical Center as lead sponsor.

NCT NCT02233101
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02233101 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Oral vs. Intravenous TXA Study Proposal: TJA
Lead sponsor
Rush University Medical Center
Phase
Not applicable
Overall status
Completed
Start date
June 30, 2014
Completion date
August 31, 2015
Enrollment
167 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

blood loss after primary total joint arthroplasty, need for blood transfusion after total joint arthroplasty